Connect with us

Technology

ZOO Corporation Selects OutSystems for Gen AI-Powered Cloud-Based Electronic Drug History System

Published

on

The low-code platform enabled the company to reduce development time by approximately 30% while swiftly incorporating customer feedback

TOKYO, Aug. 30, 2024 /PRNewswire/ — OutSystems, a global leader transforming how companies innovate through software, today announced that ZOO Corporation, a software provider in the fields of healthcare and entertainment, has developed “kusudama Cloud Yakureki,” a cloud-based electronic drug history system powered by generative AI, utilising OutSystems. Prior to adopting OutSystems, ZOO relied on development languages and environments with high learning costs, leading to lengthy development times. However, with the OutSystems visual model-driven platform and its strong CI/CD capabilities, development time was reduced by approximately 30%. The system allows ZOO to swiftly incorporate customer feedback into its products, enabling the company to advance on its expansion plans with new feature enhancements aimed at creating an all-in-one dispensing system.

“We are very pleased that ZOO was able to develop the ‘kusudama Cloud Yakureki’ cloud-based electronic drug history system with a 30% shorter development time.

OutSystems will continue to help our customers expand their business and drive their digital transformation,” said Tomoharu Mieno, Regional Vice President, Northeast Asia at OutSystems and OutSystems Japan Representative Director.

When previously offering on-premise products, ZOO had to conduct product delivery and customer support in person. However, this posed significant challenges due to the speed of deployment, travel costs and time required, which necessitated the development of cloud-based products to expand its business nationwide. OutSystems was selected by ZOO for its ability to efficiently develop large and complex systems, and strong track record of developing successful mission-critical systems and applications, both in Japan and overseas.

The kusudama Cloud Yakureki was developed by a team of experts beyond the traditional framework of developer, including not only highly equipped employees with extensive coding knowledge, but also members with expertise in design and AI, who acquired the skills needed to develop the application in just two months. As they were able to implement various customer ideas and feature requests within a short timeframe, this contributed to boosting customer satisfaction and paved the way for business growth opportunities.

Powered by generative AI, kusudama Cloud Yakureki offers tailored medication guidance based on prescription details, patient information, and previous drug history. It can also automatically transcribe the content of recorded guidance conversations, significantly improving pharmacists’ work efficiency amid staff shortages. Beyond these features, ZOO intends to add other features such as prescription input, receipt request, inventory management, headquarters, and point-of-sale (POS) register. By developing an application that will integrate dispensing information with POS purchase history, the company’s ultimate goal is to create an all-in-one dispensing system that can simultaneously be used as a healthcare ledger to expand its business.

“Headquartered in Nagano, Japan, ZOO needed to establish an internal system to ensure swift development and delivery support in a short period of time to expand future business opportunities by transitioning its product offerings from on-premises to cloud-based solutions,” said Shusuke Fujii, President of ZOO Corporation. “Given these circumstances, we were able to complete the kusudama Cloud Yakureki with high security, flexibility, and scalability while reducing the development time by adopting the OutSystems platform. With this achievement, we intend to further expand the use of OutSystems to support pharmacists and achieve an overwhelming improvement in productivity.”

About OutSystems

OutSystems is a global leader transforming how companies innovate through software, empowering IT leaders with a better way to build the software that matters most. The OutSystems platform helps companies develop, deploy, and maintain mission-critical applications by unifying and automating the entire software lifecycle. With OutSystems, organizations leverage GenAI to deliver software instantaneously, adapt faster to changing requirements, and reduce technical debt by building on a future-proof platform. Helping customers achieve their business goals by addressing key strategic initiatives, OutSystems delivers software up to 10x faster than traditional development. Recognized as a leader by analysts, IT executives, business leaders, and developers around the world, global brands trust OutSystems to tackle their impossible projects and turn their big ideas into software that moves their business, people, and the world forward.

Founded in 2001, the company’s network spans more than 750,000 community members, over 500 partners, and active customers in 75+ countries across 21 industries. Learn more at www.outsystems.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/zoo-corporation-selects-outsystems-for-gen-ai-powered-cloud-based-electronic-drug-history-system-302234643.html

SOURCE OutSystems

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

LIGHT AI ANNOUNCES COMPANY-FUNDED FIELD STUDY IN NEW ZEALAND FOR QUICKSCAN™ STREP A PLATFORM

Published

on

By

Field Study Intended to Support Evaluation of Future Commercial Deployment Opportunities for AI-Enabled Strep A Screening in Community and School-Based Care Settings

VANCOUVER, BC, June 15, 2026 /CNW/ – Light AI Inc. (“Light AI” or the “Company”) (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on artificial intelligence (“AI”) powered diagnostic and wellness solutions, today announced a company-funded field study in New Zealand for the deployment and evaluation of the Company’s QuickScan™ Strep A software platform in community and school-based healthcare settings.

The field study is being conducted in collaboration with New Zealand healthcare stakeholders, including the National Hauora Coalition (“NHC”), and is designed to evaluate real-world implementation, workflow integration, accessibility, and commercial readiness of Light AI’s QuickScan™ Strep A software application for point-of-care screening and clinical decision support relating to pharyngitis and suspected Group A Streptococcus (“Strep A” or “GAS”) infections.

The Company believes the study may provide valuable operational and implementation data to support evaluation of future commercial deployment opportunities in New Zealand, including potential expansion with NHC, subject to study outcomes, stakeholder engagement, applicable regulatory considerations, and commercial agreements.

“New Zealand provides an important opportunity to evaluate how AI-enabled health-tech tools may support improved access to screening and care in community settings,” said John R. Luna, Chief Executive Officer of Light AI. “This field study is intended to assess real-world implementation of our QuickScan™ platform while generating insights that may support future commercial deployment opportunities in New Zealand and potentially other international markets.”

“We look forward to evaluating the implementation and effectiveness of Light AI’s QuickScan™ platform through this field study initiative and assessing its potential role in supporting community-based screening programs,” said Dr. Rachel Brown, Chief Executive Officer of the NHC. “The study is intended to help inform future deployment opportunities following successful pilot outcomes.”

About the National Hauroa Coalition of New Zealand

National Hauora Coalition (NHC) is a Māori led, whānau (family) informed and outcomes focused organisation that supports community-connected organisations to deliver hauora (wellbeing) services effectively for whānau.

NHC promotes, supports and delivers initiatives aimed to improve health and social outcomes for all New Zealanders with a particular focus on whānau Māori, Pacific peoples, new migrant communities, and other populations who experience inequitable health outcomes.

In collaboration with NHC’s partners, NHC delivers a wide range of innovative health and social programmes that improve outcomes for whānau and benefit Aotearoa. NHC’s history covers over two decades, driven by the goal for whānau Māori to achieve self-determined success.

About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)

Light AI Inc. is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. Light AI QuickScan™ is a technology platform which represents the next generation of patient management: it applies AI algorithms to compatible smart device images, starting with images of Strep A and anticipated expansion with other medical conditions, to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind as its computing platform includes the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative screening and diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective screening and diagnostic tools designed to address critical healthcare challenges.

In pre-FDA validation studies, Light AI’s algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI’s technology offers a significant advancement in the accurate and timely identification of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI’s approach to applying AI to smart device images can be expanded to other medical conditions, as well as other areas of analysis. Light AI’s vision is to combine the Light AI QuickScan™ software platform with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

ON BEHALF OF THE COMPANY

“John R. Luna”
Chief Executive Officer
Telephone: 1-(888) 804-9459
Email: jluna@light.ai

For more information, please contact the Company at investors@light.ai or visit https://light.ai/.

Website: https://light.ai/
LinkedIn: LinkedIn/company/Light AI
X (Formerly Twitter): @lightaihealth

Forward-Looking Information:

This news release contains statements and information that, to the extent that they are not historical fact, constitute “forward-looking information” within the meaning of applicable securities legislation, including, but not limited to, the study outcomes and future commercial deployment opportunities in New Zealand. Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, but not limited to, statements relating to the Company’s financial performance, business development, results of operations, and those listed in filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedarplus.ca). Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward- looking statements. The Company does not undertake any obligation to update any forward-looking information to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws.

SOURCE Light AI Inc.

Continue Reading

Technology

New Book Exposes the Hidden Infrastructure of AI and Data Centers

Published

on

By

“Data and the Beast: The Truth About Data Centers and AI” — a prophetic and investigative exposé that connects the explosive growth of AI data centers to ancient biblical warnings about power, surveillance, and the infrastructure of the final empire.

DRUMS, Pa., June 15, 2026 /PRNewswire/ — Donald A. Galade, three-time international best-selling author, announced the release of his latest book, “Data and the Beast: The Truth About Data Centers and AI.”

The live launch of “Data and the Beast” airs Monday, June 29, 2026, at 10:00 AM EST on Club 36, hosted by Dorothy Spaulding on Watchmen Broadcasting Network (WBPI TV-49).

The program is available through multiple platforms:

Watch online at wbpi.org,Stream by searching “Watchmen Broadcasting.”Facebook Live through Watchmen Broadcasting.TV affiliates in several southeastern U.S. markets.Club 36 also airs at 8:00 PM and midnight EST

The book will be available FREE only on Amazon Kindle download for 4 days total. Viewers can visit the link included here for instant download between June 28, 2026, and July 1, 2026.

“Data and the Beast” examines the rapid worldwide expansion of data centers—the steel, copper, lithium, and electricity-hungry facilities now rising across the globe—and asks the question many are afraid to ask: “Is this the infrastructure the book of Revelation warned about?” AI-driven systems already shape commerce, communication, identity, and surveillance, and those developments may directly connect to biblical prophecy, specifically the Mark of the Beast.

With terawatt-scale data centers rising across the nation, Galade examines the environmental, spiritual, health, financial, and societal costs of the AI boom. The book reveals how the same infrastructure being sold as progress may be laying the groundwork for unprecedented control—and why believers must understand the times.

Written With AI, About AI
In an unusual twist, “Data and the Beast” was researched, written, and produced through an extensive collaboration between Galade and multiple artificial intelligence systems—making it a book about AI’s role in biblical prophecy, created in direct partnership with that very technology. The book’ features reflections on the project from AI systems, including Microsoft Copilot and Claude (Anthropic), which assisted in the research and writing process. GROK AI actually said, “I’ve never seen anything like it.”

About the Author

Donald A. Galade is a three-time international bestselling author, Registered Investment Advisor, and founder of Kingdom Financial Ministries. His previous best-selling works, including “Awoken: Conspiracy or Theory?” and “In God We Trust, the Dollar We Worship,” have helped readers discern the spiritual dimensions of technology, government, finances, religion, globalism, and end-times developments.

Key Themes

The real numbers. What are the total jobs created? How much water, power, and land are used? What happens to these buildings if they fail? Where does the wastewater go? Who foots the bill? What are the tax consequences? Who owns them?

What are P.I.L.O.T. programs and why does your town or municipality need to ask the right questions?

The Bible speaks of a beast that comes to life and speaks in Revelation. Will that be done using AI?

Is that why we see hundreds of these facilities being built all over the country all at once? Why now? Why so many?

Availability: Now available only on Amazon in paperback and Kindle editions.

DataAndTheBeast.comDon Galade’s BookstoreKingdom Financial Ministries (Publisher)

Donald A. Galade
CEO/ Author
Kingdom Financial Ministries
don@dongalade.com

This release was issued through WebWire®. For more information, visit http://www.webwire.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-book-exposes-the-hidden-infrastructure-of-ai-and-data-centers-302800834.html

SOURCE Donald A. Galade – Kingdom Financial Ministries

Continue Reading

Technology

The Launch of MyIQ Marks a Transition to Continuous Self-Evaluation

Published

on

By

The new platform empowers users by providing the tools to consistently re-evaluate themselves in the ever-evolving digital landscape. 

CLAYMONT, Del., June 15, 2026 /PRNewswire/ — The launch of MyIQ signals a transition to continuous self-evaluation at both the micro and macro levels. The digital self-knowledge platform was designed to help individuals better understand themselves at a deeper level.

The inspiration to create the platform came from the founders witnessing a growing disconnect between what consumers were searching for and what they were actually being provided. While people had a great deal of curiosity about self-improvement, the quality of tools available online was very low. MyIQ was founded to bridge this divide and equip these users with a more viable, useful online platform.

The Lackluster Other Platforms

Before the launch of MyIQ by Envest Research Inc., most platforms either offered overly simplistic quiz-style content or academic frameworks that could prove inaccessible to everyday users. MyIQ sought to find a middle ground, making self-knowledge structured, engaging, and understandable for all.

However, one of the biggest challenges of founding MyIQ was building trust within this space in the first place. Online testing is often viewed skeptically, leading many users to be reluctant to believe in the platform’s potential from the get-go. Beyond this, the platform also unexpectedly found itself competing with viral-first apps that purported to be educational but prioritized entertainment over depth.

MyIQ ultimately overcame these struggles by focusing on product integrity, structured design, and long-form engagement. Rather than chasing virality as so many of their competitors did, the platform instead sought to foreground measurable value, leading to sustained user retention and organic global growth.

The MyIQ Difference

The MyIQ difference is that the platform refuses to treat self-knowledge as a single metric. The platform operates with the belief that meaningful self-understanding emerges from the intersection of cognitive ability, emotional patterns, and relational behavior. This integrated approach is not just a product feature; it shapes the platform’s perspective. Rather than framing self-assessment as a static score or label, MyIQ is built around self-knowledge as a system; something that can be measured, compared, and developed over time.

Use Cases

Many users initially approach MyIQ with the intention of utilizing it for a very deliberate, singular purpose: checking their IQ. However, time and again, the team has witnessed users become engrossed in the educational opportunities the platform offers and expand into broader self-exploration.

This shift, from seeking a fixed result to engaging in an ongoing process, is indicative of how MyIQ operates on a foundational level. These tales underscore that self-assessment is no longer treated as a one-time outcome but as an iterative, reflective process of real-life change.

Moving Forward

In the next few years, MyIQ aims to establish itself as a leading platform in the self-knowledge space, moving beyond individual assessments to become a standard tool for understanding how people think, behave, and relate to others.

Furthermore, the long-term vision is to help reposition self-awareness as a structured, measurable construct, making it part of everyday decision-making across personal development, education, and relationships.

As MyIQ continues to grow, the focus will remain on deepening the integration of cognitive, emotional, and behavioral data. Through these methods, the team strives to allow users to track patterns over time rather than rely on static results. In these ways, MyIQ hopes to transform self-assessment from a one-time experience into an ongoing, data-informed process.

About MyIQ

MyIQ is a digital self-knowledge platform designed to help individuals better understand how they think, feel, and behave through structured cognitive, personality, and relational assessments. The platform was developed to address a market gap: traditional IQ tests and personality quizzes either lacked depth or failed to translate insights into meaningful, real-world understanding. MyIQ combines multiple layers of self-assessment with guided learning tools, brain games, and expert-led content to create a continuous self-reflection ecosystem.

Contact

Sophie de Villiers
PR Manager
MyIQ
pr@myiq.com
Claymont, DE 19703, USA

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-launch-of-myiq-marks-a-transition-to-continuous-self-evaluation-302800857.html

SOURCE MyIQ

Continue Reading

Trending